1Trinmaarchi JM, Fairchild B, Verona R, et al. E2F-6,a member of E2F family that can behave as a transcriptional repressor[J].Proc Natl Acad Sci USA,1998,996:2850-2855.
2Simpson JF, Quan De, Malley F, et al. Amplification of CCND1 and expression its protein product, CyclinD1: in ductal carcinoma in situ of the breast[J].AM J Pathol,1997,151:161-168.
3Fracchiolla NS, Pruneri G, Pignataro L,et al. Mollecular and immunohistochemical analysis of the bcl-1/CyclinD1 gene in laryneal squamous cell carcinoma[J]. Cancer,1997,79:1114.
4Nichols GE, Williams ME, Gaffey MG, et al. CyclinD1 gene expression in human cervical neoplasia[J]. Mad Pathol,1996,9:418-425.
6Charron T, Nili N, Strauss BH. The cell cycle:A critical therapeutic target to prevent vascular proliferative disease[J]. Can J Cardiol, 2006, 22(1) :41-55.
7Campbell MA. Dormancy and the cell cycle[J]. Genet Eng (NY), 2006, 27:21-33.
8Golias CH, Charalabopoulos A, Charalabopoulos K. Cell proliferation and cell cycle control: a mini review[J]. Int J Clin Pract, 2004, 58(12):1134-1141.
9Morgan DO. Principles of CDK regulation[J]. Nature, 1995, 374 (6518):131-142.
10Tashiro E, Tsuchiya A, Imoto M. Functions of eyclin D1 as an oncogene and regulation of cyelin D1 expression[J]. Cancer Sci, 2007, 98(5):629-635.
